Cargando…
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
Autores principales: | Rätze, Max A. K., Koorman, Thijs, Sijnesael, Thijmen, Bassey-Archibong, Blessing, van de Ven, Robert, Enserink, Lotte, Visser, Daan, Jaksani, Sridevi, Viciano, Ignacio, Bakker, Elvira R. M., Richard, François, Tutt, Andrew, O’Leary, Lynda, Fitzpatrick, Amanda, Roca-Cusachs, Pere, van Diest, Paul J., Desmedt, Christine, Daniel, Juliet M., Isacke, Clare M., Derksen, Patrick W. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232389/ https://www.ncbi.nlm.nih.gov/pubmed/35610485 http://dx.doi.org/10.1038/s41388-022-02355-1 |
Ejemplares similares
-
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
por: Rätze, Max A. K., et al.
Publicado: (2022) -
Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions
por: Sflomos, George, et al.
Publicado: (2021) -
LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice
por: ter Steege, Eline J., et al.
Publicado: (2022) -
Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer
por: Vlug, Eva J., et al.
Publicado: (2013) -
αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer
por: de Groot, Jolien S, et al.
Publicado: (2018)